VALIDATION IMAGES
IF(ICC) staining with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:200 in 293T cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:200 in Hela cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:200 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human cervix tissue incubated with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human liver cancer tissue incubated with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human liver tissue incubated with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human spleen tissue incubated with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Flow cytometric analysis of Hela cells with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at a 1:50 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).
Paraformaldehyde-fixed and paraffin-embedded Mouse spleen tissue incubated with TP53BP1 (2C6) Monoclonal Antibody (bsm-52979R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.